About Halsted Pharma Private Limited
Data last updated:
Halsted Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 02 September 2022.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24290TG2022PTC166288.
The company has an authorised share capital of ₹25 Cr and a paid-up capital of ₹24.76 Cr. It is led by directors including Harsh Kumar Saxena (Whole-Time Director) and Nagesh Kumar Middey.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Ground Floor Plot No.25 – Hig Phase Xv Kphb Colony Kukatpally, Hyderabad, Telangana, India – 500072.
As per the financials filed for FY 2025, the company reported a revenue of ₹36.78 Cr, a decline of 7% compared to the previous year. For the same year it recorded a net loss of ₹5.73 Cr (net margin -15.6%) and EBITDA of -₹5.03 Cr (EBITDA margin -13.7%).
The company has about 85 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Halsted Pharma. As per MCA filings, the company has open charges of ₹8 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website halstedpharma.com.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressGround Floor Plot No.25 – Hig Phase Xv Kphb Colony Kukatpally, Hyderabad, Telangana, India – 500072
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Associated Brands with Halsted Pharma Private Limited
Halsted Pharma operates one associated brand: Halsted Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Develops and manufactures therapies for oncology, haematology, and neurology through reverse engineering. | halstedpharma.com |
Competitors & Alternatives of Halsted Pharma Private Limited
Brands and companies operating in the same space as Halsted Pharma Private Limited include Merck, Roivant Sciences, AbbVie and 7 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
 Merck | Pharmaceutical products are manufactured and marketed worldwide. | Kenilworth, United Kingdom | 1891 |
 Roivant Sciences | Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | New York, United States | 2014 |
 AbbVie | Biopharmaceutical research and drug development are conducted globally by AbbVie. | Chicago, United States | 2012 |
 Lilly | Traditional pharmaceutical medicines are developed for multiple health fields. | United States | 1876 |
 Gilead | Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | Foster City, United States | 1987 |
 United Therapeutics | Treatments for chronic and life-threatening diseases are developed and commercialized. | Silver Spring, United States | 1998 |
 Roche | Pharmaceuticals and diagnostics kits are developed for various diseases. | Basel, Switzerland | 1896 |
 Ascendis Pharma | Long-acting prodrug therapies are developed for endocrine and rare diseases. | Hellerup, Denmark | 2007 |
 MorphoSys | Therapeutic antibodies for cancer and other diseases are developed. | Planegg, Germany | 1992 |
 Vertex Pharmaceuticals | Developer of drugs for the treatment of multiple disorders | United States | 1989 |
Business Activity of Halsted Pharma Private Limited
The main business activity of Halsted Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Board of Directors of Halsted Pharma Private Limited
Halsted Pharma has 3 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nagesh Kumar Middey Also directs: Vivint Healthcare Private Limited, Vivint Laboratories Private Limited, Questus Pharma Private Limited and 3 more | Director | 09 Oct 2023 | 2 Years 11 Months | Current |
| Raghuveer Adusumilli Also directs: Vivint Healthcare Private Limited, Vivint Laboratories Private Limited, Questus Pharma Private Limited and 3 more | Director | 28 Sep 2022 | 4 Years 0 Months | Current |
| Harsh Kumar Saxena | Whole-Time Director | 17 May 2023 | 3 Years 4 Months | Current |
Financials of Halsted Pharma Private Limited FY 2025 filings available
Halsted Pharma Private Limited reported revenue of ₹36.78 Cr (down 7% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Halsted Pharma Private Limited
Revenue fell 7% in the latest year. EBITDA fell 3% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Halsted Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• |
| EBITDA | -₹5.03 Cr | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• |
| Net Profit (PAT) | -₹5.73 Cr | •••• | •••• |
| Balance Sheet | |||
| Share Capital | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• |
Financial Ratios of Halsted Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -13.7% | •••• | •••• |
| Net Profit Margin | -15.6% | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• |
| Liquidity and Debt | |||
| Current Ratio | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• |
| Efficiency and Growth | |||
| Asset Turnover | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Halsted Pharma are in the company report.
Financial statements from FY 2023
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Charges & Borrowings of Halsted Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Dec 2023 | Hdfc Bank Limited | ₹8 Cr | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Halsted Pharma Private Limited
Employment history and EPFO contributions of people linked to Halsted Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Halsted Pharma Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Halsted Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Halsted Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Halsted Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Halsted Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Halsted Pharma Private Limited
Frequently Asked Questions about Halsted Pharma Private Limited
Halsted Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 02 September 2022 (4+ years old) and is registered under CIN U24290TG2022PTC166288.
Halsted Pharma reported revenue of ₹36.78 Cr for FY 2025 (down 7% YoY).
Halsted Pharma has 3 current directors:
- Harsh Kumar Saxena - Whole-Time Director
- Nagesh Kumar Middey - Director
- Raghuveer Adusumilli - Director
Halsted Pharma reported a net loss of ₹5.73 Cr (net margin -15.6%) and EBITDA of -₹5.03 Cr (EBITDA margin -13.7%) for FY 2025, as per its filed financial statements.
The CIN (Corporate Identification Number) of Halsted Pharma is U24290TG2022PTC166288. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Halsted Pharma was incorporated on 02 September 2022, making it 4+ years old. It is registered with the Registrar of Companies, Hyderabad.
Halsted Pharma can be reached through the website halstedpharma.com. Its registered office is in Hyderabad, Telangana, India.
The registered office of Halsted Pharma is at Ground Floor Plot No.25 – Hig Phase Xv Kphb Colony Kukatpally, Hyderabad, Telangana, India – 500072.
Halsted Pharma has an authorised share capital of ₹25 Cr and a paid-up capital of ₹24.76 Cr.